Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSTP.L Regulatory News (STP)

  • There is currently no data for STP

Director/PDMR Shareholding

22 Jun 2018 11:00

RNS Number : 2301S
Stenprop Limited
22 June 2018
 

 

STENPROP LIMITED

(Registered in Guernsey)

(Registration number 64865)

LSE share code: STP JSE share code: STP

ISIN: GG00BFWMR296

("Stenprop" or the "Company")

 

 

DEALINGS IN SECURITIES BY A DIRECTOR OF A MAJOR SUBSIDIARY OF THE COMPANY AND ISSUE OF NEW SHARES

 

 

22 June 2018

 

Shareholders are advised of the following information relating to the acceptance of market value options awarded on 7 June 2018 under the Stenprop Limited Long Term Incentive Plan ("Long Term Incentive Plan"). The market value options will vest in three tranches on 31 March 2019, 31 March 2020 and 31 March 2021 and once fully vested will result in the issue of 95 816 shares subject to the payment of the exercise price of £1.10 per share, for a deemed value of £105 397.60.

 

Name of director:

Name of subsidiary companies:

Nicolaas Marais

Stenprop (UK) Limited and Stenprop (Germany) Limited

Transaction date:

7 June 2018

Class of securities:

Market value options

Number of securities:

95 816

Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:

Off-market acceptance of market value options in terms of the Long Term Incentive Plan

Direct beneficial

Yes

 

Shareholders are further advised of the following information relating to the acceptance of nil cost options awarded on 7 June 2018 under the Stenprop Limited Amended Deferred Share Bonus Plan ("Deferred Bonus Plan"). One third of these nil cost options vested immediately, with the second third vesting on 31 March 2019 and the last third vesting on 31 March 2020. Once fully vested, they will result in the issue of 18 363 shares.

 

Name of director:

Name of subsidiary companies:

Nicolaas Marais

Stenprop (UK) Limited and Stenprop (Germany) Limited

Transaction date:

7 June 2018

Class of securities:

Nil cost options

Number of securities:

18 363

Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:

Off-market acceptance of nil cost options in terms of the Deferred Bonus Plan

Direct beneficial

Yes

 

Shareholders are further advised of the exercise of nil cost options awarded under the Deferred Bonus Plan, comprising 6 121 nil cost options granted on 7 June 2018, which vested immediately, 3 675 options awarded on 8 June 2017 which vested on31 March 2018 and 5 283 options awarded on 9 June 2016 which vested on 31 March 2018, which will result in the issuance of 15 079 shares, in each case at a deemed value of £1.185 per share.

 

Name of director:

Name of subsidiary companies:

Nicolaas Marais

Stenprop (UK) Limited and Stenprop (Germany) Limited

Transaction date:

20 June 2018

Class of securities:

Nil cost options

Number of securities:

15 079

Deemed total value:

Nature of transaction:

Nature and extent of director's interest:

Clearance to deal received:

£17,868.61

Off-market exercise of nil cost options in terms of the Deferred Bonus Plan

Direct beneficial

Yes

 

Following the transaction, Nicolaas Marais' beneficial interest in the Company is 295 679 shares, representing approximately 0.10% of the issued capital of the Company.

 

ISSUE OF NEW SHARES

 

Application has been made for 50 819 new ordinary shares to be admitted to the Specialist Fund Segment of the London Stock Exchange and to the Main Board of the JSE. This application includes the above 15 079 vested options exercised by Nicolaas Marais and an additional 35 740 ordinary shares in relation to the exercise of additional nil cost options by an employee of the Stenprop group in terms of the Deferred Bonus Plan. It is expected that admission will take place at 8.00 am on 26 June 2018.

 

 

 

Enquiries:

 

Stenprop Limited

Paul ArensonPatsy WatsonJulian Carey

+44(0)20 7079 6600

 

Numis Securities Limited (Financial Adviser)

Hugh JonathanVicki Paine

+44(0)20 7260 1000

 

Tavistock (PR adviser)

James Whitmore

James Verstringhe

Kirsty Allan

+44(0)20 7920 3150

 

JSE Sponsor

Java Capital Trustees and Sponsors Proprietary Limited

+ 27 (0) 11 722 3050

 

About Stenprop

Stenprop is a Guernsey-registered UK REIT. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to www.stenprop.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFKBDPOBKKFAB
Date   Source Headline
18th Oct 20077:01 amRNSFinal Results
20th Aug 20077:01 amRNSAIM Rule 26 and Adviser Name
30th Jul 20077:01 amRNSBank Loan Facility
18th Jul 20075:29 pmRNSHolding(s) in Company
28th Jun 20077:03 amRNSTrading Update
18th Jun 20077:01 amRNSMajor VoIP Customer Trial
4th Jun 20074:21 pmRNSNotice of EGM
31st May 20077:00 amRNSTotal Voting Rights
23rd May 200711:43 amRNSDirectorate Change
9th May 20075:04 pmRNSGrant of Options
4th May 20075:40 pmRNSNotifiable Interest
25th Apr 20075:52 pmRNSNotifiable Interest
11th Apr 20075:00 pmRNSHolding(s) in Company
4th Apr 20072:40 pmRNSConvertible Equity Facility
3rd Apr 20078:48 amRNSDirectorate Change
5th Mar 20077:04 amRNSDirectorate Change
5th Mar 20077:01 amRNSAcquisition
5th Feb 20077:02 amRNSTelstra Platinum Partner
2nd Feb 200712:00 pmRNSGrant of Options
30th Jan 20077:02 amRNSInterim Results
11th Dec 20064:15 pmRNSVoting Share capital
6th Dec 20067:01 amRNSDeputy Chairman Appointment
28th Nov 20062:34 pmRNSNotice of EGM
27th Nov 200612:02 pmRNSIssue of Equity
27th Nov 20067:02 amRNSOxfam 118 918 Partnership
30th Oct 20067:02 amRNSAnnual Report and AGM Notice
19th Oct 20067:00 amRNSIssue of Equity
16th Oct 20067:01 amRNSAcquisition
29th Sep 20067:06 amRNSIssue of Equity
12th Sep 20067:04 amRNSAcquisition of Callplan Ltd
29th Aug 20062:15 pmRNSIssue of Equity
28th Jul 20062:06 pmRNSAward of Share Options
27th Jul 200612:29 pmRNSBuy-out of Spiritel Tech
25th Jul 20067:01 amRNSDirector's Dealing
24th Jul 20067:01 amRNSDirector's dealings
21st Jul 200612:27 pmRNSIssue of Equity
19th Jul 200612:13 pmRNSDebt Restructuring
5th Jul 20067:01 amRNSIssue of Convertible Loan
21st Jun 20067:02 amRNSLaunches VoipVoucher
28th Apr 20061:11 pmRNSResult of EGM
6th Apr 20062:08 pmRNSNotice of EGM
6th Apr 20067:01 amRNSBoard Changes
31st Mar 20065:28 pmRNSNotification of Interest
27th Mar 20067:02 amRNSSigns 1st My Phone Agreement
24th Mar 20064:40 pmRNSNotification of Interest
20th Mar 20067:02 amRNSManaged Services Contract
6th Mar 20067:03 amRNSLoan Note Conversion
3rd Mar 20066:27 pmRNSLoan Note Conversion
22nd Feb 20061:39 pmRNSNotification of Interest
21st Feb 20065:50 pmRNSDirectors' Dealing-Correction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.